Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Miltefosine Plus IL Pentamidine for Bolivian CL
Phase 2
Completed
- Conditions
- Leishmaniasis, Cutaneous
- Interventions
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2018-02-27
- Lead Sponsor
- Jonathan Berman
- Target Recruit Count
- 50
- Registration Number
- NCT03445897
News
No news found